Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FPARL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,038
Award facts
- Contract value 100% obligated
- $4,038.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,038.48 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. Issued on September 4, 2025, with an ultimate completion date of September 5, 2025, this firm fixed-price delivery order was awarded without set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products to support medical supply requirements across Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in Defense Logistics Agency procurement markets. The company's extensive contract portfolio with the agency demonstrates its capability to deliver diverse pharmaceutical products ranging from branded and generic prescription medications to biologics and specialty medical consumables. This particular delivery order for Ozempic aligns with the company's established role in providing prescription medications to military healthcare facilities and reflects the ongoing demand for pharmaceutical supplies across the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DB25FPARL?
SPE2DB25FPARL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FPARL worth?
The government has obligated $4,038 on SPE2DB25FPARL.
Is contract SPE2DB25FPARL an order under another contract?
Yes. SPE2DB25FPARL is a delivery order under SPE2DB25D9336, an indefinite delivery contract.
Was contract SPE2DB25FPARL competed?
The extent of competition for SPE2DB25FPARL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award